Demo terms

Riyaan demonstrates one way to organize starting-cell evidence, surface uncertainty, identify blockers, and prioritize follow-up work. Access to the public workspace does not create a consulting, clinical, fiduciary, legal, supplier, or customer relationship.

The site is not clinical, medical, quality, regulatory, legal, intellectual-property, biosafety, or procurement advice. It does not certify a cell line, predict patient outcomes, establish population coverage, grant commercial rights, or show that a product is suitable for research, manufacturing, or use in people.

Qualified teams must independently verify primary sources, rights, laboratory results, quality systems, regulatory requirements, and program-specific risks before acting.

You may view and evaluate the public demo for lawful purposes. You must not:

• submit or attempt to expose patient data, individual genomic data, credentials, or confidential material;
• interfere with the site, bypass access controls, introduce malicious code, or disrupt service for others;
• misrepresent demonstration outputs as validated scientific, clinical, commercial, or regulatory conclusions; or
• remove source attribution or imply that a cited third party endorses Riyaan or the demo’s interpretation.

Demo content may be incomplete, simplified, synthetic, or transcribed from public materials. It can contain errors or become outdated. A source link is provided for traceability where available; it does not transfer ownership, grant reuse rights, or guarantee the linked material’s accuracy or availability.

Respect the copyright, database, confidentiality, and other rights that apply to source materials. If demonstration content appears inaccurate or inappropriate, contact Riyaan so it can be reviewed.

The public demo is provided as available for evaluation. Features, records, scoring rules, and access may change or stop without notice. No promise is made that the site will be uninterrupted, complete, error-free, or fit for a particular use.

Send questions or content concerns to [email protected]. Do not include sensitive data in an introductory email.